Floatz logo

Therapeutic Asset Ratings

470 results matching 1 filter

129,767 assets · 8,707 sponsors · 3,128 indications
Methodology v0.2
AssetSponsorPhaseRating
Ethiodized Oil
Systemic Therapy
Sun Yat-sen UniversityN/AD (30)
Ethiodized Oil
Transcatheter Arterial Chemoembolization
Sun Yat-sen UniversityN/AD (30)
Irinotecan
Anti-PD1/PDL1 Antibody
Sun Yat-sen UniversityD (30)
Irinotecan
Cryoablation
Sun Yat-sen UniversityN/AD (30)
Irinotecan
Pulmonary Metastases
Sun Yat-sen UniversityN/AD (30)
LENVATINIB
Anti-PD1 Antibody
Sun Yat-sen UniversityN/AD (30)
LENVATINIB
Camrelizumab
Sun Yat-sen UniversityN/AD (30)
LENVATINIB
Liver Disorder
Sun Yat-sen UniversityN/AD (30)
LENVATINIB
Microwave Ablation
Sun Yat-sen UniversityN/AD (30)
LENVATINIB
PD-1 Inhibitor
Sun Yat-sen UniversityD (30)
LENVATINIB
Sintilimab
Sun Yat-sen UniversityN/AD (30)
LENVATINIB
Transcatheter Arterial Chemoembolization
Sun Yat-sen UniversityN/AD (30)
Pyrotinib
Anti-PD1/PDL1 Antibody
Sun Yat-sen UniversityD (30)
Pyrotinib
Bevacizumab
Sun Yat-sen UniversityD (30)
Pyrotinib
Lenvatinib
Sun Yat-sen UniversityD (30)
Pyrotinib
PD-1 Inhibitor
Sun Yat-sen UniversityD (30)
rc48-adc
Anti-PD1/PDL1 Antibody
Sun Yat-sen UniversityD (30)
rc48-adc
Bevacizumab
Sun Yat-sen UniversityD (30)
rc48-adc
Lenvatinib
Sun Yat-sen UniversityD (30)
rc48-adc
PD-1 Inhibitor
Sun Yat-sen UniversityD (30)
Theprubicin
Ablation
Sun Yat-sen UniversityN/AD (30)
Theprubicin
Anti-PD1 Antibody
Sun Yat-sen UniversityN/AD (30)
Theprubicin
Local Therapy
Sun Yat-sen UniversityN/AD (30)
Theprubicin
Surgery
Sun Yat-sen UniversityD (30)
Theprubicin
Systemic Therapy
Sun Yat-sen UniversityN/AD (30)
Showing 426 to 450 of 470 assets
PreviousPage 18 of 19Next